IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 4209 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (513 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
  Study Subjects
   Sample Size Calc...
  Randomization
  Blinding
   Statistical Meth...
  Ethical Issues

 Article Access Statistics
    Viewed1212    
    Printed10    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTERS TO THE EDITOR - LETTER IN RESPONSE TO PREVIOUSLY PUBLISHED ARTICLES
Year : 2018  |  Volume : 84  |  Issue : 3  |  Page : 310

Authors' reply


1 Department of Dermatology, Rajarajeshwari Medical College and Hospitals, Tumkur, Karnataka, India
2 Department of Quality Assurance, GRY Institute of Pharmacy, Khargone, Madhya Pradesh, India
3 Department of Preventive Medicine, Oxford Institute of Medical Sciences and Research Centre Bengaluru, Tumkur, Karnataka, India
4 Department of Microbiology, Sri Siddhartha Medical College, Tumkur, Karnataka, India

Date of Web Publication04-Apr-2018

Correspondence Address:
Dr. Nagaraju Umashankar
Department of Dermatology, Rajarajeshwari Medical College and Hospital, Mysore Road, Bengaluru - 560 074, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdvl.IJDVL_259_18

Rights and Permissions



How to cite this article:
Umashankar N, Pemmanda B, Gopkumar P, Hemalatha A J, Priya K S, Prashanth H V. Authors' reply. Indian J Dermatol Venereol Leprol 2018;84:310

How to cite this URL:
Umashankar N, Pemmanda B, Gopkumar P, Hemalatha A J, Priya K S, Prashanth H V. Authors' reply. Indian J Dermatol Venereol Leprol [serial online] 2018 [cited 2020 Jun 6];84:310. Available from: http://www.ijdvl.com/text.asp?2018/84/3/310/229300




Sir,

We appreciate the queries raised by the correspondent on our article “Effectiveness of topical green tea against multidrug resistant Staphylococcus aureus in cases of primary pyoderma: An open controlled trial” published in the March-April (2018) issue of the journal.

Kindly find our replies below on each point.


  Study Subjects Top


Multidrug resistance was an incidental finding and was not included in our inclusion criteria. As multidrug resistant strains were seen in 89.1% participants in the green tea group and 81.1% in the placebo group, we included this in the title.


  Sample Size Calculation Top


The first part of the study was a cross-sectional study to identify the cases among school children; later, the identified cases were administered the intervention. Hence, sample size calculation was done using the same formula.


  Randomization Top


We agree with the comments, but since this was an open label clinical trial, not much emphasis was given on randomization.


  Blinding Top


This was mentioned in the 'limitations' section.


  Statistical Methods Used Top


It is true that means of continuous variables, such as age and duration of lesion, cannot be compared; this was not done in our study. However, for your information, it was only compared for gender (categorical nominal variable) and P value was calculated, which is mentioned below in the table.


  Ethical Issues Top


Informed consent was taken from the parents. Assent forms were also obtained.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.




 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow